Rapid Micro Biosystems (RPID) Operating Margin (2020 - 2026)

Rapid Micro Biosystems has disclosed Operating Margin across 7 years of filings, most recently posting 173.11% for Q1 2026.

• Operating Margin for Q1 2026 came in at 173.11%, down 1126.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 144.2% (up 1537.0% YoY), and the FY2025 annual result was 141.1%, up 3686.0% from the prior year.
• Operating Margin came in at 173.11% for Q1 2026 at Rapid Micro Biosystems, down from 108.23% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 108.23% in Q4 2025 to a low of 394.6% in Q4 2022.
• The 5-year median for Operating Margin is 202.15% (2024), against an average of 234.99%.
• Across the five-year window, Operating Margin slumped 18742 bps in 2022 and surged 20227 bps in 2023, its largest moves.
• Rapid Micro Biosystems' Operating Margin stood at 394.6% in 2022, then surged by 51 bps to 192.33% in 2023, then surged by 35 bps to 124.47% in 2024, then grew by 13 bps to 108.23% in 2025, then slumped by 60 bps to 173.11% in 2026.
• The last three Operating Margin figures came in at 173.11% (Q1 2026), 108.23% (Q4 2025), and 145.09% (Q3 2025), per Business Quant data.